Page 166 - Orange Book Cumulative Supplement 10 October 2012
P. 166

A - 29
                 PATENT & EXCLUSIVITY DRUG PRODUCT        LIST    -   CUMULATIVE SUPPLEMENT  10  - October 2012
                                          See List footnote   for information regarding List content

                                                PATENT                     PATENT                   EXCLUSIVITY
                                              EXPIRATION      PATENT       DELIST    EXCLUSIVITY    EXPIRATION
               APPL/PROD                         DATE                    REQUESTED                     DATE
                   NO         PATENT NO                       CODES                    CODE(S)
             METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE - PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
               A090406 002                                                               PC        Feb  13, 2013
             METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET
               N021410 001     8236345      Oct  07, 2022     DP
             METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET
               N021410 002     8236345      Oct  07, 2022     DP

             METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET
               N021410 003     8236345      Oct  07, 2022     DP
             METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET
               N021410 004     8236345      Oct  07, 2022     DP
             METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET
               N021410 005     8236345      Oct  07, 2022     DP
             METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR
               N202270 001     6303661      Apr  24, 2017        U-1227
                               6340475      Sep  19, 2016     DP
                               6635280      Sep  19, 2016     DP
                               6699871      Jul  26, 2022   DS DP U-1227
                               6890898      Feb  02, 2019        U-1228
                               7078381      Feb  02, 2019        U-1227
                               7125873      Jul  26, 2022     DP U-1227
                               7326708      Apr  11, 2026   DS DP U-1227
                               7459428      Feb  02, 2019        U-1227
             METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR
               N202270 002     6303661      Apr  24, 2017        U-1227
                               6340475      Sep  19, 2016     DP
                               6635280      Sep  19, 2016     DP
                               6699871      Jul  26, 2022   DS DP U-1227
                               6890898      Feb  02, 2019        U-1228
                               7078381      Feb  02, 2019        U-1227
                               7125873      Jul  26, 2022     DP U-1227
                               7326708      Apr  11, 2026   DS DP U-1227
                               7459428      Feb  02, 2019        U-1227

             METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR
               N202270 003     6303661      Apr  24, 2017        U-1227
                               6340475      Sep  19, 2016     DP
                               6635280      Sep  19, 2016     DP
                               6699871      Jul  26, 2022   DS DP U-1227
                               6890898      Feb  02, 2019        U-1228
                               7078381      Feb  02, 2019        U-1227
                               7125873      Jul  26, 2022     DP U-1227
                               7326708      Apr  11, 2026   DS DP U-1227
                               7459428      Feb  02, 2019        U-1227
             METHYLNALTREXONE BROMIDE - RELISTOR
               N021964 001     8247425      Dec  31, 2030        U-1185
             METHYLNALTREXONE BROMIDE - RELISTOR
               N021964 002     8247425      Dec  31, 2030        U-1185
   161   162   163   164   165   166   167   168   169   170   171